These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 14270309)
1. [COMPARATIVE STUDY OF THE METHODS OF DETERMINING HEPARIN IN THE BLOOD]. ANDREENKO GV; BAZAZIAN GG; SMYSLOVA SN; RYZHAKOVA VG Lab Delo; 1965; 2():102-5. PubMed ID: 14270309 [No Abstract] [Full Text] [Related]
2. [METHODS OF DETERMINING HEPARIN SUITABLE FOR THE HOSPITAL PHYSICIAN]. VAN NISPENE Pharm Weekbl; 1964 Apr; 99():414-24. PubMed ID: 14147235 [No Abstract] [Full Text] [Related]
3. [Studies on plasma hypercoagulability. 3. An improved method for plasma heparin determination based on metachromatic activity and its levels in human plasma]. Satake K Naika Hokan; 1969 May; 16(5):173-81. PubMed ID: 5387636 [No Abstract] [Full Text] [Related]
4. [THE THROMBIN TIME. ITS VALUE IN COAGULATION TESTING]. FAVRE-GILLY J; THOUVEREZ JP; BELLEVILLE J Hemostase; 1963; 3():351-8. PubMed ID: 14151022 [No Abstract] [Full Text] [Related]
5. [NATURE OF THE INTERACTION OF AMIDOSCHWARZ AND PROTEINS]. BADIN J; HERVE B Bull Soc Chim Biol (Paris); 1965; 47():515-26. PubMed ID: 14332096 [No Abstract] [Full Text] [Related]
6. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test. Lipiński B; Worowski K Thromb Diath Haemorrh; 1968 Nov; 20(1):44-9. PubMed ID: 4236938 [No Abstract] [Full Text] [Related]
7. The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy. Benoit R; Nougier C; Desmurs-Clavel H; Simon M; Dargaud Y Int J Lab Hematol; 2022 Apr; 44(2):371-378. PubMed ID: 34643035 [TBL] [Abstract][Full Text] [Related]
8. Naked eye detection of infertility based on sperm protamine-induced aggregation of heparin gold nanoparticles. Vidya R; Saji A Anal Bioanal Chem; 2018 May; 410(13):3053-3058. PubMed ID: 29582121 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin. Bhargava AS; Heinick J; Günzel P Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289 [TBL] [Abstract][Full Text] [Related]
11. [A method of determining heparin in blood plasma based on its antithrombin activity]. Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI Lab Delo; 1990; (12):59-61. PubMed ID: 1710698 [TBL] [Abstract][Full Text] [Related]
12. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture. Soulier JP; Gozin D; Lerable J Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779 [TBL] [Abstract][Full Text] [Related]
13. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine]. Seiler K; Müller G; Duckert F Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716 [No Abstract] [Full Text] [Related]
14. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system]. Domula M; Weissbach G Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669 [TBL] [Abstract][Full Text] [Related]
15. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential). Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272 [TBL] [Abstract][Full Text] [Related]
16. Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin. Porter P; Porter MC; Shanberge JN Clin Chim Acta; 1967 Aug; 17(2):189-200. PubMed ID: 6035543 [No Abstract] [Full Text] [Related]